Name | Tengonermin |
---|
Description | Tengonermin (ARENEGYR) is a vascular-targeting agent consisting of the human Tumour Necrosis Factor-α (TNF-α) conjugated with the CNGRCG peptide. Tengonermin increases penetration of intratumoral chemotherapy and T-cell infiltration by modifying the tumour microenvironment[1][2]. |
---|---|
Related Catalog | |
In Vitro | NGR-hTNF 是一种实体瘤治疗剂,通过 NGR 基序特异性靶向血管生成肿瘤血管[1]。 |
References |
No Any Chemical & Physical Properties |